Zejula: Understanding Its Role as a Targeted Cancer Treatment
Zejula, also known by its generic name niraparib, is a cancer-targeted drug. It is typically prescribed as a "maintenance" treatment to adult women with certain types of cancer, mainly ovarian epithelial, fallopian tube, or primary peritoneal cancer. Zejula belongs to...
